Necrotic Tissue Surgical Debridement Pyoderma Gangrenosum Necrotic Material Cutaneous Ulcer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brown RF: The management of traumatic tissue loss in the lower limb, especially when complicated by skeletal injury. Br J Plast Surg 1965; 18:26–50PubMedGoogle Scholar
  2. 2.
    Monafo WW, Freedman B: Topical therapy for burns. Surg Clin North Am 1987; 67:133–145PubMedGoogle Scholar
  3. 3.
    Witkowski JA, Parish LC: Debridement of cutaneous ulcers: Medical and surgical aspects. Int J Dermatol 1992;9:585–591Google Scholar
  4. 4.
    Reed BR, Clark RA: Cutaneous tissue repair: Practical implications of current knowledge. J Am Acad Dermatol 1985; 13:919–941PubMedGoogle Scholar
  5. 5.
    Bates-Jansen BM: Management of necrotic tissue. In:Sussman C, Bates-Jensen BM (eds): Wound Care, 1st edn. Gaithersburg: Aspen Publishers. 1998; pp 139–158Google Scholar
  6. 6.
    Clark RA: Cutaneous tissue repair: Basic biologic considerations. J Am Acad Dermatol 1985; 13:701–725PubMedGoogle Scholar
  7. 7.
    Winter GD: Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193:293–294PubMedGoogle Scholar
  8. 8.
    Steed DL, Donohoe D, Webster MW et al: Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996; 183: 61–64PubMedGoogle Scholar
  9. 9.
    Fisher JC: Skin grafting. In: Georgiades GS, Riefkohl R, Levin LS (eds): Plastic, Maxillofacial and Reconstructive Surgery, 3rd edn. Baltimore: Williams & Wilkins 1996; pp 13–18Google Scholar
  10. 10.
    Marcusson JA, Lindgren C, Berghard A, et al: Allgeneic cultured keratinocytes in the treatment of leg ulcers: A pilot study. Acta Derm Venereol (Stockh) 1992; 72:61–64Google Scholar
  11. 11.
    Teepe RG, Roseeuw DI, Hermans J, et al: Randomized trial comparing cryopreserved cultured epidermal allgrafts with hydrocolloid dressings in healing chronic venous ulcers. J Am Acad Dermatol 1993; 29: 982–988PubMedGoogle Scholar
  12. 12.
    Pham HT, Rosenblum BI, Lyons TE, et al: Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective, ramdomized, dinical trial. Wounds 1999; 11:79–86Google Scholar
  13. 13.
    Raffetto JD, Mendez MV, Phillips TJ, et al: The effect of passage number on fibroblast cellular senescence in patients with chronic venous insufficiency with and without ulcer. Am J Surg 1999; 178:107–112CrossRefPubMedGoogle Scholar
  14. 14.
    Mendez MV, Stanley A, Park HY, et al: Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. J Vasc Surg 1998; 28:876–883PubMedGoogle Scholar
  15. 15.
    Agren MS, Steenfos HH, Dabelsteen S, et al: Proliferation and mitogenis response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 1999; 112: 463–469CrossRefPubMedGoogle Scholar
  16. 16.
    Feedar JA: Clinical management of chronic wounds. In: McCulloch JM, Kloth LC, Feedar JA (eds): Wound Healing: Alternatives in Management, 2nd edn. Philadelphia. F.A. Davis Company: 1995; pp 137–185Google Scholar
  17. 17.
    Holm J, Andren B, Grafford K: Pain control in the surgical debridement of leg ulcers by the use of a topical lidocaine-prilocaine cream, Emla. Acta Derm Venereol 1990; 70:132–136PubMedGoogle Scholar
  18. 18.
    Vanscheidt W, Sadjadi Z, Lillieborg S: EMLA anaesthetic cream for sharp leg ulcer debridement: a review of the clinical evidence for analgesic efficacy and tolerability. Eur J Dermatol 2001; 11:90–96PubMedGoogle Scholar
  19. 19.
    Wolff K, Stingl G: Pyoderma gangrenosum. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI and Fitzpatrick TB (eds) Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill. 1999; pp 1140–1148Google Scholar
  20. 20.
    Schwaegerle SM, Bergfeld WF, Senitzer D, et al: Pyoderma gangrenosum: A review. J Am Acad Dermatol 1988;18:559–568PubMedGoogle Scholar
  21. 21.
    Hopfl R, Hefel L, Fritsch P: Pyoderma gangraenosum: differential diagnosis in ulcus cruris and postoperative exacerbating processes. Wien Med Wochenschr 1994; 144:279–280PubMedGoogle Scholar
  22. 22.
    McCalmont CS, Leshin B, White WL, et al: Vulvar pyoderma gangraenosum. Int J Gynaecol Obstet 1991; 35:175–178CrossRefPubMedGoogle Scholar
  23. 23.
    Ergun T, Gurbuz O, Harvell J et al: The histopathology of pathergy: a chronologic study of skin hyper-reactivity in Behçet's disease. Int J Dermatol 1998; 37:929–933CrossRefPubMedGoogle Scholar
  24. 24.
    Gul A, Esin S, Dilsen N, et al: Immunohistology of skin pathergy reaction in Behcet's disease. Br J Dermatol 1995; 132:901–907PubMedGoogle Scholar
  25. 25.
    Gonzales AZ, Gonzales E: Pyoderma gangrenosum: self assessment. J Am Acad Dermatol 1990; 23: 545–548Google Scholar
  26. 26.
    Odom BO, James WD, Berger TG (eds): Erythema and urticaria. In: Andrews' Diseases of the Skin: Clinical Dermatology, 9th edn. Philadelphia: W.B. Saunders. 2000; pp 146–171Google Scholar
  27. 27.
    Odom BO, James WD, Berger TG (eds): Disorders of mucous membranes. In: Andrews' Diseases of the Skin: Clinical Dermatology, 9th edn. Philadelphia: W.B. Saunders. 2000; pp 991–1010Google Scholar
  28. 28.
    Glenchur H, Patel BS, Pathmarajah C: Transient bacteremia associated with debridement of decubitus ulcers. Mil Med 1981; 146:432–433PubMedGoogle Scholar
  29. 29.
    Schmeller W, Gaber Y, Gehl HB: Shave therapy is a simple, effective treatment of persistent venous leg ulcers. J Am Acad Dermatol 1998; 39:232–238PubMedGoogle Scholar
  30. 30.
    Marquez RR: Wound debridement and hydrotherapy. In: Gogia pp (ed): Clinical Wound Management, 1st edn. New Jersey: Slack Incorporated. 1995; pp 115–130Google Scholar
  31. 31.
    Steve L, Goodhart P, Alexander J: Hydrotherapy burn treatment: Use of chloramine T against resistant microorganisms. Arch Phys Med Rehabil 1979; 60:301–303PubMedGoogle Scholar
  32. 32.
    Thomlinson RH: Kitchen remedy for necrotic malignant breast ulcers. Lancet 1980; 2:707CrossRefPubMedGoogle Scholar
  33. 33.
    Chirife J, Scarmato G, Herszage L: Scientific basis for the use of granulated sugar in treatment of infected wounds. Lancet 1982; 1:560–561CrossRefPubMedGoogle Scholar
  34. 34.
    Cooper RA, Molan PC, Harding KG: Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. J R Soc Med 1999; 92: 283–285PubMedGoogle Scholar
  35. 35.
    Efem SE: Clinical observations on the wound healing properties of honey. Br J Surg 1988; 75:679–681PubMedGoogle Scholar
  36. 36.
    Zumla A, Lulat A: Honey — a remedy rediscovered. J R Soc Med 1989; 82:384–385PubMedGoogle Scholar
  37. 37.
    Molan PC: Potential of honey in the treatment of wounds and burns. Am J Clin Dermatol 2001; 2: 13–19PubMedGoogle Scholar
  38. 38.
    Sieggreen MY, Maklebust J: Debridement: Choices and challenges. Adv Wound Care 1997; 10:32–37Google Scholar
  39. 39.
    Rodeheaver GT, Baharestani M, Brabec ME, et al: Wound healing and wound management: Focus on debridement. Adv Wound Care 1994; 7:22–36Google Scholar
  40. 40.
    Howes EL, Mandl I, Zaffuto S, et al: The use of Clostridium histolyticum enzymes in the treatment of experimental third degree burns. Surg Gynecol Obstet 1959; 109:177–188PubMedGoogle Scholar
  41. 41.
    Boxer AM, Gottesman N, Bernstein H, et al: Debridement of dermal ulcers and decubiti with collagenase. Geriatrics 1969; 24:75–86Google Scholar
  42. 42.
    Poulsen J, Kristensen VN, Brygger HE, et al: Treatment of infected surgical wounds with varidase. Acta Chir Scand 1983; 149:245–248PubMedGoogle Scholar
  43. 43.
    Hellgren L, Vincent J: Degradation and liquefaction effect of streptokinase-streptodornase and stabilized trypsin on necroses, crusts of fibrinoid, purulent exudate and clotted blood from leg ulcers. J Int Med Res 1977; 5:334–337PubMedGoogle Scholar
  44. 44.
    Hellgren L: Cleansing properties of stabilized trypsin and streptokinase-streptodornase in necrotic leg ulcers. Eur J Clin Pharmacol 1983; 24:623–628PubMedGoogle Scholar
  45. 45.
    Falanga V: Wound bed preparation and the role of enzymes: A case for multiple actions of therapeutic agents. Wounds 2002; 14:47–57Google Scholar
  46. 46.
    Varma AO, Bugatch E, German FM: Debridement of dermal ulcers with collagenase. Surg Gynecol Obstet 1973; 136:281–282PubMedGoogle Scholar
  47. 47.
    Barrett D Jr, Klibanski A: Collagenase debridement. Am J Nurs 1973; 73:849–851PubMedGoogle Scholar
  48. 48. Glyantsev SP, Adamyan AA, Sakharov Y: Crab collagenase in wound debridement. J Wound Care 1997; 6:13–16PubMedGoogle Scholar
  49. 49.
    Westerhof W, Jansen FC, De Wit FS, et al: Controlled double-blind trial of fibrinolysin-desoxyribonu-clease (Elase) solution in patients with chronic leg ulcers who are treated before autologuos skin grafting. J Am Acad Dermatol 1987; 17:32–39PubMedGoogle Scholar
  50. 50.
    Falabella AF, Carson P, Eaglstein WH, et al: The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol 1998; 39:737–740PubMedGoogle Scholar
  51. 51.
    Singh GB, Snelling CFT, Hogg GR, et al: Debridement of the burn wound with sutilains ointment. Burns 1979; 7:41–48CrossRefGoogle Scholar
  52. 52.
    Makepeace AR: Enzymatic debridement of burns: a review. Burns Incl Therm Inj 1983; 9:153–157PubMedGoogle Scholar
  53. 53.
    Dimick AR: Experience with the use of proteolytic enzyme (Travase) in burn patients. J Trauma 1977; 17:948–955PubMedGoogle Scholar
  54. 54.
    Berger MM: Enzymatic debriding preparations. Ostomy Wound Manage 1993; 39:61–66PubMedGoogle Scholar
  55. 55.
    Rodeheaver G, Marsh D, Edgerton MT, et al: Proteolytic enzymes as adjuncts to antimicrobial prophylaxis in contaminated wounds. Am J Surg 1975; 129:537–544CrossRefPubMedGoogle Scholar
  56. 56.
    Alvarez OM, Fernandez-Obregon A, Roisin S, et al: A prospective, randomized, comparative study of collagenase and papain-urea for pressure ulcer debridement. Wounds 2000; 14:293–301Google Scholar
  57. 57.
    Silverstein P, Ruzicka FJ, Helmkamp GM, et al: In-vitro evaluation of enzymatic debridement of burn eschar. Surgery 1973; 73:15–22PubMedGoogle Scholar
  58. 58.
    Suomalainen O: Evaluation of two enzyme preparations: Trypure and Varidase in traumatic ulcers. Ann Chir Gynaecol 1983; 72:62–65PubMedGoogle Scholar
  59. 59.
    Nduwimana J, Guenet L, Dorval I, et al: Proteases. Ann Biol Clin 1995; 53:251–264Google Scholar
  60. 60.
    Westerhof W, Van Ginkel CJ, Cohen EB, et al: Prospective randomized study comparing the debriding effect of Krill enzymes and a non-enzymatic treatment in venous leg ulcers. Dermatologica 1990; 181:293–297PubMedGoogle Scholar
  61. 61.
    Hellgren L, Karlstam B, Mohr V, et al. Krill enzymes. A new concept for efficient debridement of necrotic ulcers. Int J Dermatol 1991; 30:102–103PubMedGoogle Scholar
  62. 62.
    Hellgren L, Vincent J: Debriding properties of krill enzymes in necrotic leg ulcers. Arch Dermatol 1989; 125:1006CrossRefPubMedGoogle Scholar
  63. 63.
    Kathleen Parfitt (ed) Aserbine. In: Martindale — The Complete Drug Reference, 32nd edn. London: The Pharmaceutical Press. 1999; pp 1678Google Scholar
  64. 64.
    Madden MR, Finkelstein JL, Hefton JM, et al: Optimal healing of donor site wounds with hydrocolloid dressing. In: Ryan TJ (ed) An Environment for Healing: The Role of Occlusion. London: Royal Society of Medicine. 1985; pp 133–137Google Scholar
  65. 65.
    Barnett A, Berkowitz, RL, Mills R, et al: Comparison of synthetic adhesive moisture vapor permeable and fine mesh gauze dressings for split-thickness skin graft donor sites. Am J Surg 1983; 145:379–381CrossRefPubMedGoogle Scholar
  66. 66.
    Mumford JW, Mumford SP: Occlusive hydrocolloid dressings applied to chronic neuropathic ulcers. Int J Dermatol 1988; 27:1900–192Google Scholar
  67. 67.
    Choucair M, Phillips T: Wound dressing. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds): Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill. 1999; pp 2954–2958Google Scholar
  68. 68.
    Colin D, Kurring PA, Yvon C, et al: Managing sloughy pressure sores. J Wound Care 1996; 5:444–446PubMedGoogle Scholar
  69. 69.
    Flanagan M: The efficacy of a hydrogel in the treatment of wounds with non-viable tissue. J Wound Care 1995; 4:264–267PubMedGoogle Scholar
  70. 70.
    Bale S, Banks V, Haglestein S, et al: A comparison of two amorphous in the debridement of pressure sores. J Wound Care 1998; 7:65–68PubMedGoogle Scholar
  71. 71.
    Rodeheaver GT: Pressure ulcer debridement and cleansing: A review of current literature. Ostomy Wound Management 1999; 45[Suppl 1A]:80S–85SGoogle Scholar
  72. 72.
    Mulder GD: Cost-effective managed care: gel versus wet-to-dry for debridement. Ostomy Wound Manage 1995; 41:68–76Google Scholar
  73. 73.
    Mumcuoglu KY: Clinical applications for maggots in wound care. Am J Clin Dermatol 2001; 2:219–227PubMedGoogle Scholar
  74. 74.
    Bear WS: The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J Bone Joint Surg 1931; 13:438–475Google Scholar
  75. 75.
    Chernin E: Surgical maggots. South Med J 1986; 79:1143–1145PubMedGoogle Scholar
  76. 76.
    Hewitt F: Osteomyelitis: Development of the use of maggots in treatment. Am J Nurs 1932; 32:31–38Google Scholar
  77. 77.
    Sherman RA: A new dressing design for use with maggot therapy. Plast Reconstr Surg 1997; 100: 451–456PubMedGoogle Scholar
  78. 78.
    Mumcuoglu KY, Ingber A, Gilead L, et al: Maggot therapy for the treatment of intractable wounds. Int J Dermatol 1999; 38:623–627CrossRefPubMedGoogle Scholar
  79. 79.
    Ziffren SE, Heist HE, May SC, et al: The secretion of collagenase by maggots and its implication. Ann Surg 1953; 138:932–934PubMedGoogle Scholar
  80. 80.
    Robinson W, Norwood VH: Destruction of pyogenic bacteria in the alimentary tract of surgical maggots implanted in infected wounds. J Lab Clin Med 1934; 19:586–581Google Scholar
  81. 81.
    Robinson W: Stimulation of healing in non-healing wounds by allantoin occurring in maggot secretions and of wide biological distribution. J Bone Joint Surg 1935; 17:267–271Google Scholar
  82. 82.
    Prete PE: Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanisms of wound healing by maggot therapy. Life Sci 1997; 60:505–510CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations